vs
Acadia Healthcare Company, Inc.（ACHC）与Mativ Holdings, Inc.（MATV）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是Mativ Holdings, Inc.的1.8倍（$829.0M vs $463.1M），Mativ Holdings, Inc.净利率更高（21.8% vs 0.5%，领先21.2%），Acadia Healthcare Company, Inc.同比增速更快（7.5% vs 1.0%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -3.8%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Mativ Holdings是一家全球特种材料制造商，主要生产高性能先进聚合物、无纺布、过滤解决方案及功能性涂层材料，服务医疗、工业、消费品、航空航天、能源等领域，业务遍及北美、欧洲及亚太地区。
ACHC vs MATV — 直观对比
营收规模更大
ACHC
是对方的1.8倍
$463.1M
营收增速更快
ACHC
高出6.5%
1.0%
净利率更高
MATV
高出21.2%
0.5%
两年增速更快
ACHC
近两年复合增速
-3.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $463.1M |
| 净利润 | $4.5M | $100.8M |
| 毛利率 | — | 18.8% |
| 营业利润率 | — | 2.2% |
| 净利率 | 0.5% | 21.8% |
| 营收同比 | 7.5% | 1.0% |
| 净利润同比 | -50.8% | 6620.0% |
| 每股收益（稀释后） | $0.05 | $1.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCMATV
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $463.1M | ||
| Q3 25 | $851.6M | $513.7M | ||
| Q2 25 | $869.2M | $525.4M | ||
| Q1 25 | $770.5M | $484.8M | ||
| Q4 24 | $774.2M | $458.6M | ||
| Q3 24 | $815.6M | $498.5M | ||
| Q2 24 | $796.0M | $523.8M |
净利润ACHCMATV
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $100.8M | ||
| Q3 25 | $36.2M | $-3.2M | ||
| Q2 25 | $30.1M | $-9.5M | ||
| Q1 25 | $8.4M | $-425.5M | ||
| Q4 24 | $32.6M | $1.5M | ||
| Q3 24 | $68.1M | $-20.8M | ||
| Q2 24 | $78.5M | $-1.4M |
毛利率ACHCMATV
| Q1 26 | — | — | ||
| Q4 25 | — | 18.8% | ||
| Q3 25 | — | 19.3% | ||
| Q2 25 | — | 19.7% | ||
| Q1 25 | — | 15.0% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 18.8% | ||
| Q2 24 | — | 20.8% |
营业利润率ACHCMATV
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 2.2% | ||
| Q3 25 | 4.7% | 3.1% | ||
| Q2 25 | 5.8% | 3.8% | ||
| Q1 25 | 1.7% | -88.8% | ||
| Q4 24 | 4.9% | 0.6% | ||
| Q3 24 | 12.1% | 1.4% | ||
| Q2 24 | 13.4% | 2.0% |
净利率ACHCMATV
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 21.8% | ||
| Q3 25 | 4.3% | -0.6% | ||
| Q2 25 | 3.5% | -1.8% | ||
| Q1 25 | 1.1% | -87.8% | ||
| Q4 24 | 4.2% | 0.3% | ||
| Q3 24 | 8.4% | -4.2% | ||
| Q2 24 | 9.9% | -0.3% |
每股收益（稀释后）ACHCMATV
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.87 | ||
| Q3 25 | $0.40 | $-0.06 | ||
| Q2 25 | $0.33 | $-0.18 | ||
| Q1 25 | $0.09 | $-7.82 | ||
| Q4 24 | $0.36 | $0.03 | ||
| Q3 24 | $0.74 | $-0.38 | ||
| Q2 24 | $0.85 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $84.2M |
| 总债务越低越好 | $2.5B | $1.0B |
| 股东权益账面价值 | $2.0B | $498.7M |
| 总资产 | $5.5B | $2.1B |
| 负债/权益比越低杠杆越低 | 1.29× | 2.07× |
8季度趋势，按日历期对齐
现金及短期投资ACHCMATV
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $84.2M | ||
| Q3 25 | $118.7M | $97.1M | ||
| Q2 25 | $131.4M | $95.6M | ||
| Q1 25 | $91.2M | $84.0M | ||
| Q4 24 | $76.3M | $94.3M | ||
| Q3 24 | $82.1M | $162.2M | ||
| Q2 24 | $77.2M | $133.4M |
总债务ACHCMATV
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $1.0B | ||
| Q3 25 | $2.3B | $1.0B | ||
| Q2 25 | $2.3B | $1.1B | ||
| Q1 25 | $2.2B | $1.1B | ||
| Q4 24 | $2.0B | $1.1B | ||
| Q3 24 | $1.9B | $1.2B | ||
| Q2 24 | $1.8B | $1.2B |
股东权益ACHCMATV
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $498.7M | ||
| Q3 25 | $3.1B | $397.4M | ||
| Q2 25 | $3.1B | $416.6M | ||
| Q1 25 | $3.0B | $428.2M | ||
| Q4 24 | $3.1B | $858.5M | ||
| Q3 24 | $3.0B | $882.3M | ||
| Q2 24 | $3.0B | $898.0M |
总资产ACHCMATV
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.1B | ||
| Q3 25 | $6.4B | $2.0B | ||
| Q2 25 | $6.3B | $2.1B | ||
| Q1 25 | $6.1B | $2.1B | ||
| Q4 24 | $6.0B | $2.4B | ||
| Q3 24 | $5.9B | $2.6B | ||
| Q2 24 | $5.7B | $2.6B |
负债/权益比ACHCMATV
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 2.07× | ||
| Q3 25 | 0.74× | 2.63× | ||
| Q2 25 | 0.74× | 2.66× | ||
| Q1 25 | 0.72× | 2.67× | ||
| Q4 24 | 0.64× | 1.30× | ||
| Q3 24 | 0.62× | 1.32× | ||
| Q2 24 | 0.62× | 1.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | — | $8.0M |
| 自由现金流率自由现金流/营收 | — | 1.7% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | 13.78× | 0.19× |
| 过去12个月自由现金流最近4个季度 | — | $93.8M |
8季度趋势，按日历期对齐
经营现金流ACHCMATV
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $19.3M | ||
| Q3 25 | $73.2M | $72.8M | ||
| Q2 25 | $133.5M | $57.6M | ||
| Q1 25 | $11.5M | $-15.9M | ||
| Q4 24 | $116.7M | $24.1M | ||
| Q3 24 | $163.1M | $37.6M | ||
| Q2 24 | $171.1M | $46.1M |
自由现金流ACHCMATV
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $8.0M | ||
| Q3 25 | $-63.0M | $66.7M | ||
| Q2 25 | $-34.2M | $48.9M | ||
| Q1 25 | $-163.2M | $-29.8M | ||
| Q4 24 | $-86.8M | $2.0M | ||
| Q3 24 | $-27.1M | $25.5M | ||
| Q2 24 | $16.9M | $37.4M |
自由现金流率ACHCMATV
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 1.7% | ||
| Q3 25 | -7.4% | 13.0% | ||
| Q2 25 | -3.9% | 9.3% | ||
| Q1 25 | -21.2% | -6.1% | ||
| Q4 24 | -11.2% | 0.4% | ||
| Q3 24 | -3.3% | 5.1% | ||
| Q2 24 | 2.1% | 7.1% |
资本支出强度ACHCMATV
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.4% | ||
| Q3 25 | 16.0% | 1.2% | ||
| Q2 25 | 19.3% | 1.7% | ||
| Q1 25 | 22.7% | 2.9% | ||
| Q4 24 | 26.3% | 4.8% | ||
| Q3 24 | 23.3% | 2.4% | ||
| Q2 24 | 19.4% | 1.7% |
现金转化率ACHCMATV
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 16.07× | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
